ArticleDisease markers2022

Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma.

Yongjie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.